OneSource Speci.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE013P01021
NSEID: ONESOURCE
BSEID: 544292
View on NSE | View on BSE

INR

1,548.80

15.1 (0.98%)

BSENSE

Sep 07, 03:14 PM

BSE+NSE Vol: 1.09 lacs

{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,548.80",
    "chg": 15.1,
    "chgp": "0.98%",
    "dir": 1,
    "prev_price": "1,533.70",
    "mcapval": "17,760.54 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE013P01021",
    "curr_date": "Sep 07, 03:14 PM",
    "curr_time": "15:16 PM",
    "last_traded_at": "Sep 07, 03:14 PM IST",
    "bse_nse_vol": "1.09 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 07, 2026",
    "traded_date_str": "2026 09 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "OneSource Specialty Pharma Ltd Faces Mildly Bearish Technical Shift Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-mildly-bearish-technical-shift-amid-market-pressure-4184857",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OneSourceSpecia_technicaldot_4184857.png",
        "date": "2026-09-07 08:04:40",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid recent price declines and sector headwinds."
      },
      {
        "title": "OneSource Specialty Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-ltd-is-rated-sell-4181002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OneSourceSpecia_mojoScore_4181002.png",
        "date": "2026-09-03 10:11:03",
        "description": "OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Faces Technical Setback Amid Broader Market Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-technical-setback-amid-broader-market-weakness-4176995",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OneSourceSpecia_technicaldot_4176995.png",
        "date": "2026-09-01 08:07:48",
        "description": "OneSource Specialty Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, as recent indicator signals suggest a complex outlook for the pharmaceutical small-cap. Despite a modest daily decline of 1.19%, the stock’s technical parameters reveal mixed signals that warrant close attention from investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Faces Technical Downshift Amid Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-technical-downshift-amid-bearish-momentum-4170947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OneSourceSpecia_technicaldot_4170947.png",
        "date": "2026-08-27 08:04:51",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. Recent technical indicators, including MACD, RSI, and moving averages, suggest increasing pressure on the stock, which has underperformed the broader market benchmarks over multiple time frames."
      },
      {
        "title": "OneSource Specialty Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-ltd-is-rated-sell-4165922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OneSourceSpecia_mojoScore_4165922.png",
        "date": "2026-08-23 10:10:27",
        "description": "OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis below reflects the stock's current position as of 23 August 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Faces Technical Shift Amidst Weak Price Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-technical-shift-amidst-weak-price-momentum-4161980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OneSourceSpecia_technicaldot_4161980.png",
        "date": "2026-08-20 08:05:48",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a nuanced picture that investors should carefully analyse amid broader market pressures."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Declines 1.69%: Mixed Technical Signals Shape Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-declines-169-mixed-technical-signals-shape-weekly-performance-4154947",
        "imagepath": "",
        "date": "2026-08-15 09:04:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>10 Aug:</strong> Stock opens at ₹1,575.00, technical momentum softens</p>\n                    <p><strong>11 Aug:</strong> Technical momentum shifts to mildly bullish; MarketsMOJO upgrades rating to Hold</p>\n                    <p><strong>12 Aug:</strong> Mixed financial signals with operational improvements but profitability concerns</p>\n                    <p><strong>13 Aug:</strong> Technical momentum shifts back to sideways amid market pressure; stock declines 3.65%</p>\n                    <p><strong>14 Aug:</strong> Week closes at ₹1,551.70, down 1.26% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div..."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Faces Technical Momentum Shift Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-technical-momentum-shift-amid-market-pressure-4151150",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OneSourceSpecia_technicaldot_4151150.png",
        "date": "2026-08-13 08:03:54",
        "description": "OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture of bearish signals on weekly charts contrasted by mildly bullish daily moving averages, signalling a period of consolidation and uncertainty for investors."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-ltd-upgraded-to-hold-amid-mixed-financial-and-technical-signals-4149584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OneSourceSpecia_mojoScore_4149584.png",
        "date": "2026-08-12 08:46:12",
        "description": "OneSource Specialty Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and financial performance despite ongoing challenges in management efficiency and valuation metrics."
      }
    ],
    "total": 253,
    "sid": "10039523",
    "stock_news_url": "https://www.marketsmojo.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Sep-2026",
      "details": "Intimation of the investor presentation",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Sep-2026",
      "details": "Newspaper advertisement confirming the dispatch of the notice convening the 19th AGM of the Company and Remote e-voting",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "31-Aug-2026",
      "details": "Annual Report for FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

OneSource Specialty Pharma Ltd Faces Mildly Bearish Technical Shift Amid Market Pressure

2026-09-07 08:04:40

OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid recent price declines and sector headwinds.

Read full news article

OneSource Specialty Pharma Ltd is Rated Sell

2026-09-03 10:11:03

OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

OneSource Specialty Pharma Ltd Faces Technical Setback Amid Broader Market Weakness

2026-09-01 08:07:48

OneSource Specialty Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, as recent indicator signals suggest a complex outlook for the pharmaceutical small-cap. Despite a modest daily decline of 1.19%, the stock’s technical parameters reveal mixed signals that warrant close attention from investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

OneSource Specialty Pharma Ltd Faces Technical Downshift Amid Bearish Momentum

2026-08-27 08:04:51

OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. Recent technical indicators, including MACD, RSI, and moving averages, suggest increasing pressure on the stock, which has underperformed the broader market benchmarks over multiple time frames.

Read full news article

OneSource Specialty Pharma Ltd is Rated Sell

2026-08-23 10:10:27

OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis below reflects the stock's current position as of 23 August 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.

Read full news article

OneSource Specialty Pharma Ltd Faces Technical Shift Amidst Weak Price Momentum

2026-08-20 08:05:48

OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a nuanced picture that investors should carefully analyse amid broader market pressures.

Read full news article

OneSource Specialty Pharma Ltd Declines 1.69%: Mixed Technical Signals Shape Weekly Performance

2026-08-15 09:04:38

Key Events This Week

10 Aug: Stock opens at ₹1,575.00, technical momentum softens

11 Aug: Technical momentum shifts to mildly bullish; MarketsMOJO upgrades rating to Hold

12 Aug: Mixed financial signals with operational improvements but profitability concerns

13 Aug: Technical momentum shifts back to sideways amid market pressure; stock declines 3.65%

14 Aug: Week closes at ₹1,551.70, down 1.26% on the day

Read full news article

OneSource Specialty Pharma Ltd Faces Technical Momentum Shift Amid Market Pressure

2026-08-13 08:03:54

OneSource Specialty Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture of bearish signals on weekly charts contrasted by mildly bullish daily moving averages, signalling a period of consolidation and uncertainty for investors.

Read full news article

OneSource Specialty Pharma Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals

2026-08-12 08:46:12

OneSource Specialty Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators and financial performance despite ongoing challenges in management efficiency and valuation metrics.